Cencora, Inc. (COR) Revenue by Segment

Cencora revenue by segment at a glance

In Q3 fiscal 2026 (the quarter ended June 30, 2026), Cencora's largest business segment was U.S. Healthcare Solutions, with $74.86 billion or 91% of revenue, up 4.9% from a year earlier. Next: International Healthcare Solutions (9%).

The fastest-growing business segment from a year earlier was International Healthcare Solutions (+5.9%).

From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q1 fiscal 2018.

Cencora, Inc.

CORHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

U.S. Healthcare SolutionsPharmaceutical DistributionInternational Healthcare SolutionsCorporate and otherAll other segmentsOther Operating

Q3 FY26 breakdown

Fiscal quarter ended Jun 30, 2026

Item	Revenue	Share	vs year before
U.S. Healthcare Solutions	USD 74.86B	90.7%	+4.9%
International Healthcare Solutions	USD 7.68B	9.3%	+5.9%
Corporate and otheri	USD 2.25B		+6.9%
Intersegment eliminationsi	-USD 39.71M		–

Sum of items USD 82.54B; corporate items and eliminations USD 2.21B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18
U.S. Healthcare Solutions	74.9B	68.8B	76.2B	75.8B	71.3B	66.8B	72.6B	71.7B	67.2B	61.3B	65.2B	61.9B	59.9B	56.7B	56.2B	–	53.4B	50.9B	53.0B	–	50.4B	48.2B	51.6B	–	–	–	–	–	–	–	–	–	–	–	–
Pharmaceutical Distribution	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	43.6B	45.6B	46.0B	43.9B	43.5B	41.7B	43.7B	41.7B	41.6B	39.5B	38.9B
International Healthcare Solutions	7.7B	7.6B	7.6B	7.9B	7.3B	6.7B	7.0B	7.4B	7.1B	7.1B	7.1B	7.0B	7.0B	6.8B	6.6B	–	6.7B	6.8B	6.6B	–	3.0B	989.0M	944.3M	–	–	–	–	–	–	–	–	–	–	–	–
Corporate and other	2.3B	2.1B	2.1B	–	2.1B	2.0B	2.0B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
All other segments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.8B	1.9B	1.8B	1.8B	1.7B	1.7B	1.7B	–	–	–	–
Other Operating	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.6B	1.6B	1.6B	1.5B

Cencora revenue by business segment, last 4 quarters

Business segment	Q3 FY26	Q2 FY26	Q1 FY26	Q3 FY25	Share
U.S. Healthcare Solutions	$74.9B	$68.8B	$76.2B	$71.3B	91%
International Healthcare Solutions	$7.7B	$7.6B	$7.6B	$7.3B	9%

In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.

Questions and answers

What are Cencora's business segments?

U.S. Healthcare Solutions and International Healthcare Solutions (as reported for Q3 fiscal 2026).

Which business segment makes the most money for Cencora?

U.S. Healthcare Solutions: $74.86 billion, or 91% of revenue, in Q3 fiscal 2026.

MoreCencora stock overview Cencora financials Cencora executive team Cencora shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.